Duan Dayue
Functional Genomics and Proteomics Laboratory, Center of Biomedical Research Excellence, Department of Pharmacology, University of Nevada, School of Medicine, Reno, NV 89557, USA.
J Physiol. 2009 May 15;587(Pt 10):2163-77. doi: 10.1113/jphysiol.2008.165860. Epub 2009 Jan 26.
Recent studies have identified several chloride (Cl-) channel genes in the heart, including CFTR, ClC-2, ClC-3, CLCA, Bestrophin, and TMEM16A. Gene targeting and transgenic techniques have been used to delineate the functional role of cardiac Cl- channels in the context of health and disease. It has been shown that Cl- channels may contribute to cardiac arrhythmogenesis, myocardial hypertrophy and heart failure, and cardioprotection against ischaemia-reperfusion. The study of physiological or pathophysiological phenotypes of cardiac Cl- channels, however, may be complicated by the compensatory changes in the animals in response to the targeted genetic manipulation. Alternatively, tissue-specific conditional or inducible knockout or knockin animal models may be more valuable in the phenotypic studies of specific Cl- channels by limiting the effect of compensation on the phenotype. The integrated function of Cl- channels may involve multi-protein complexes of the Cl- channel subproteome and similar phenotypes can be attained from alternative protein pathways within cellular networks, which are influenced by genetic and environmental factors. Therefore, the phenomics approach, which characterizes phenotypes as a whole phenome and systematically studies the molecular changes that give rise to particular phenotypes achieved by modifying the genotype (such as gene knockouts or knockins) under the scope of genome/proteome/phenome, may provide a more complete understanding of the integrated function of each cardiac Cl- channel in the context of health and disease.
最近的研究已经在心脏中鉴定出了几种氯离子(Cl-)通道基因,包括囊性纤维化跨膜传导调节因子(CFTR)、氯离子通道蛋白2(ClC-2)、氯离子通道蛋白3(ClC-3)、钙激活氯离子通道蛋白(CLCA)、贝斯特蛋白(Bestrophin)和跨膜蛋白16A(TMEM16A)。基因靶向和转基因技术已被用于阐明心脏Cl-通道在健康和疾病背景下的功能作用。研究表明,Cl-通道可能与心律失常的发生、心肌肥大和心力衰竭以及对缺血-再灌注的心脏保护有关。然而,对心脏Cl-通道生理或病理生理表型的研究可能会因动物对靶向基因操作的代偿性变化而变得复杂。另外,组织特异性条件性或诱导性敲除或敲入动物模型在特定Cl-通道的表型研究中可能更有价值,因为它可以限制代偿对表型的影响。Cl-通道的整合功能可能涉及Cl-通道亚蛋白质组的多蛋白复合物,并且在细胞网络中,通过替代蛋白途径可以获得相似的表型,这些途径受遗传和环境因素的影响。因此,表型组学方法将表型表征为一个整体的表型组,并在基因组/蛋白质组/表型组范围内系统地研究通过改变基因型(如基因敲除或敲入)产生特定表型的分子变化,这可能会更全面地了解每个心脏Cl-通道在健康和疾病背景下的整合功能。